US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

BioNexus Gene Lab Corp.

1.43

-0.1200-7.74%

Post-market: 1.430.00000.00%16:56 EDT

Volume:21.84K

Turnover:29.13K

Market Cap:4.19M

PE:-1.15

High:1.49

Open:1.49

Low:1.24

Close:1.55

52wk High:6.10

52wk Low:1.07

Shares:2.93M

Float Shares:1.88M

Volume Ratio:7.73

T/O Rate:1.16%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.2467

EPS(LYR):-1.6075

ROE:-33.66%

ROA:-18.99%

PB:0.54

PE(LYR):-0.89

Loading ...

Overview Company News Filings

BioNexus Q2 FY26 Net Loss Narrows 53.51% to $286,451; Revenue Drops 96.63% to $76,156 vs Year-Ago Quarter

BioNexus Gene Lab Files Initial Beneficial Ownership Statement for Fidelion Diagnostics Pte. Ltd

BioNexus Gene Lab Names CFO Chong Set Fui in Initial Beneficial Ownership Filing

BioNexus Advances VitaGuard Southeast Asia Rollout After China Hospital Visits

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:15 PM

BioNexus CEO speaks at China-Malaysia Economic Cooperation Outlook Forum in Kuala Lumpur

BioNexus Gene Lab CEO urges Malaysia-China biotech co-development at economic forum in Kuala Lumpur

BioNexus Gene Lab Corp. Calls for Malaysia–China Biotechnology Cooperation to Move Beyond Trade into Co-Development

BioNexus Q1 FY26 net loss narrows to $543,575; revenue drops 98.93% to $22,842

BioNexus Gene Lab FY25 net loss widens 86.7% to $2.98 million; revenue falls 21.9% to $7.42 million

BioNexus Gene Lab expects delayed 2025 10-K filing after governance review

BioNexus Gene Lab names Muthu Meyyappan chief commercial officer of Fidelion Diagnostics

Press Release: BioNexus Gene Lab Corp. Announces Appointment of Dr. Muthu Meyyappan as Chief Commercial Officer of Fidelion Diagnostics to Lead Global Commercialization of the VitaGuard(TM) MRD Platform

Bionexus Gene Lab appoints Matthew Barsing as Chairman

BioNexus Subsidiary Chemrex Names Matthew Barsing Chairman

BioNexus Gene Lab Corp. Completes Chemrex Governance Restructuring; Appoints Matthew Barsing as Chairman

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://nz.tigrwd.com/stock/BGLC/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BGLC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BGLC\",,,,,undefined,":{"symbol":"BGLC","market":"US","secType":"STK","nameCN":"BioNexus Gene Lab Corp.","latestPrice":1.43,"timestamp":1787774400000,"preClose":1.55,"halted":0,"volume":21844,"hourTrading":{"tag":"盘后","latestPrice":1.43,"preClose":1.43,"latestTime":"16:56 EDT","volume":3,"amount":4.19,"timestamp":1787777797182,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.07741935483870975,"floatShares":1881000,"shares":2933399,"eps":-1.2467,"marketStatus":"Not Yet Opened","change":-0.12,"latestTime":"08-26 16:00:00 EDT","open":1.4924,"high":1.4924,"low":1.24,"amount":29129,"amplitude":0.162839,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.2467,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787817600000},"marketStatusCode":0,"adr":0,"listingDate":1689825600000,"exchange":"NASDAQ","adjPreClose":1.55,"postHourTrading":{"tag":"盘后","latestPrice":1.43,"preClose":1.43,"latestTime":"16:56 EDT","volume":3,"amount":4.19,"timestamp":1787777797182,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":7.725825},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BGLC\",,,,,undefined,":{"symbol":"BGLC","floatShares":1881000,"roa":"-18.99%","roe":"-33.66%","lyrEps":-1.607496,"volumeRatio":7.725825,"shares":2933399,"dividePrice":0,"high":1.4924,"amplitude":0.162839,"preClose":1.55,"low":1.24,"week52Low":1.07,"pbRate":"0.54","psRate":"1.34","week52High":6.1,"institutionHeld":0,"latestPrice":1.43,"eps":-1.2467,"divideRate":0,"volume":21844,"delay":0,"ttmEps":-1.2467,"open":1.4924,"prevYearClose":3.95,"prevWeekClose":1.59,"prevMonthClose":1.32,"prevQuarterClose":1.95,"fiveDayClose":1.57,"twentyDayClose":1.36,"sixtyDayClose":2.24},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BGLC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-04-07","symbol":"BGLC","defaultRemindTime":1744032600000,"type":"split","dateTimestamp":1743998400000,"forFactor":10,"toFactor":1,"ratio":10},{"market":"US","date":"2023-07-20","symbol":"BGLC","defaultRemindTime":1689859800000,"type":"split","dateTimestamp":1689825600000,"forFactor":1000000,"toFactor":83333,"ratio":12.000048000192}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BGLC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BGLC\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BGLC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BGLC","date":"2026-08-25","current":-1.147028,"percent":0.915694,"low":-471.528444,"twenty":-5.708224,"median":-3.423912,"eighty":-2.572957,"high":-1.098456,"avg":-9.51233,"sd":32.601753,"marketCap":4546835},"quantilePoints":[{"date":"2023-07-06","current":-176.823166,"twenty":-176.823166,"median":-176.823166,"eighty":-176.823166,"marketCap":78173168},{"date":"2023-07-14","current":-471.528444,"twenty":-416.045263,"median":-332.820492,"eighty":-239.222096,"marketCap":208461782},{"date":"2023-07-21","current":-159.468227,"twenty":-406.064578,"median":-322.211103,"eighty":-162.939215,"marketCap":70500584},{"date":"2023-07-28","current":-76.673253,"twenty":-330.698614,"median":-184.702373,"eighty":-113.030056,"marketCap":33897092},{"date":"2023-08-04","current":-71.273729,"twenty":-322.211103,"median":-142.728572,"eighty":-75.23338,"marketCap":31509973},{"date":"2023-08-11","current":-41.036388,"twenty":-194.832842,"median":-107.9905,"eighty":-58.314869,"marketCap":18142105},{"date":"2023-08-18","current":-31.110617,"twenty":-192.581581,"median":-74.33346,"eighty":-38.156642,"marketCap":17505540},{"date":"2023-08-25","current":-37.115283,"twenty":-176.823166,"median":-67.314077,"eighty":-33.340847,"marketCap":20884287},{"date":"2023-09-01","current":-53.785707,"twenty":-159.468227,"median":-57.780238,"eighty":-37.115283,"marketCap":30264518},{"date":"2023-09-08","current":-32.711774,"twenty":-132.684778,"median":-52.370294,"eighty":-36.360396,"marketCap":18406490},{"date":"2023-09-15","current":-29.402853,"twenty":-113.030056,"median":-49.382198,"eighty":-32.837589,"marketCap":16544603},{"date":"2023-09-22","current":-30.510021,"twenty":-108.710436,"median":-43.916136,"eighty":-32.460145,"marketCap":17167592},{"date":"2023-09-29","current":-27.364657,"twenty":-89.200152,"median":-41.216373,"eighty":-30.696856,"marketCap":15397737},{"date":"2023-10-06","current":-22.646613,"twenty":-76.097304,"median":-39.788842,"eighty":-29.468277,"marketCap":12742955},{"date":"2023-10-13","current":-19.54214,"twenty":-74.513444,"median":-37.115283,"eighty":-27.175936,"marketCap":10996108},{"date":"2023-10-20","current":-16.607515,"twenty":-72.569616,"median":-34.441725,"eighty":-24.446566,"marketCap":9344833},{"date":"2023-10-23","current":-13.213669,"twenty":-72.137653,"median":-34.284457,"eighty":-23.753315,"marketCap":7435160},{"date":"2023-11-03","current":-11.826564,"twenty":-68.897938,"median":-32.903073,"eighty":-20.751847,"marketCap":6654654},{"date":"2023-11-10","current":-11.543482,"twenty":-64.858708,"median":-32.082701,"eighty":-19.55535,"marketCap":6495367},{"date":"2023-11-17","current":-10.694233,"twenty":-60.27764,"median":-30.822985,"eighty":-17.041576,"marketCap":6017506},{"date":"2023-11-24","current":-5.149203,"twenty":-57.887164,"median":-30.153992,"eighty":-12.992236,"marketCap":15928694},{"date":"2023-12-01","current":-5.425784,"twenty":-55.861647,"median":-29.402853,"eighty":-12.4808,"marketCap":16784279},{"date":"2023-12-08","current":-4.506257,"twenty":-52.653377,"median":-27.364657,"eighty":-11.581226,"marketCap":13939786},{"date":"2023-12-15","current":-3.860874,"twenty":-50.703252,"median":-26.735585,"eighty":-10.506141,"marketCap":11943340},{"date":"2023-12-21","current":-3.398254,"twenty":-50.137086,"median":-25.480617,"eighty":-7.056239,"marketCap":10512259},{"date":"2023-12-29","current":-2.99846,"twenty":-49.57092,"median":-23.752344,"eighty":-5.147406,"marketCap":9275523},{"date":"2024-01-05","current":-2.939062,"twenty":-48.124054,"median":-22.646613,"eighty":-4.622769,"marketCap":9091779},{"date":"2024-01-12","current":-2.868241,"twenty":-45.308557,"median":-20.74996,"eighty":-4.064426,"marketCap":8872700},{"date":"2024-01-19","current":-2.655208,"twenty":-43.814111,"median":-20.127294,"eighty":-3.952141,"marketCap":8213696},{"date":"2024-01-26","current":-3.095553,"twenty":-43.004079,"median":-19.54214,"eighty":-3.819752,"marketCap":9575873},{"date":"2024-02-02","current":-2.53941,"twenty":-41.324364,"median":-18.219783,"eighty":-3.215491,"marketCap":7855484},{"date":"2024-02-09","current":-2.558686,"twenty":-41.007054,"median":-13.213669,"eighty":-3.086415,"marketCap":7915113},{"date":"2024-02-16","current":-6.510941,"twenty":-40.449367,"median":-12.837799,"eighty":-3.06106,"marketCap":20141135},{"date":"2024-02-23","current":-4.706725,"twenty":-38.687965,"median":-12.583024,"eighty":-3.08413,"marketCap":14559921},{"date":"2024-03-01","current":-3.250331,"twenty":-38.156642,"median":-12.210298,"eighty":-3.095553,"marketCap":10054667},{"date":"2024-03-08","current":-4.405737,"twenty":-37.115283,"median":-11.590663,"eighty":-3.100979,"marketCap":13628835},{"date":"2024-03-15","current":-4.049349,"twenty":-35.857137,"median":-10.694233,"eighty":-3.152095,"marketCap":12526373},{"date":"2024-03-22","current":-4.310929,"twenty":-34.598992,"median":-10.38127,"eighty":-3.1698,"marketCap":13335552},{"date":"2024-03-28","current":-3.997947,"twenty":-34.347364,"median":-9.67326,"eighty":-3.234225,"marketCap":12367364},{"date":"2024-04-05","current":-3.563884,"twenty":-33.529569,"median":-6.510941,"eighty":-3.359532,"marketCap":11024621},{"date":"2024-04-12","current":-3.819603,"twenty":-33.017851,"median":-5.99692,"eighty":-3.39597,"marketCap":11819666},{"date":"2024-04-19","current":-5.702751,"twenty":-32.882655,"median":-5.425784,"eighty":-3.443945,"marketCap":14992778},{"date":"2024-04-26","current":-3.982383,"twenty":-32.743228,"median":-5.003144,"eighty":-3.456282,"marketCap":10469857},{"date":"2024-05-03","current":-4.096626,"twenty":-32.208516,"median":-4.750703,"eighty":-3.478442,"marketCap":10770207},{"date":"2024-05-10","current":-3.998512,"twenty":-31.305034,"median":-4.609633,"eighty":-3.536423,"marketCap":10512259},{"date":"2024-05-17","current":-3.78062,"twenty":-30.88177,"median":-4.409735,"eighty":-3.55686,"marketCap":10070567},{"date":"2024-05-24","current":-3.608171,"twenty":-30.822041,"median":-4.401739,"eighty":-3.562845,"marketCap":9611208},{"date":"2024-05-31","current":-2.817556,"twenty":-30.634577,"median":-4.297222,"eighty":-3.472959,"marketCap":7505221},{"date":"2024-06-07","current":-3.684446,"twenty":-30.082786,"median":-4.255895,"eighty":-3.45255,"marketCap":9814385},{"date":"2024-06-14","current":-2.931638,"twenty":-29.659033,"median":-4.216976,"eighty":-3.385163,"marketCap":7809105},{"date":"2024-06-21","current":-3.069598,"twenty":-29.500989,"median":-4.16618,"eighty":-3.266915,"marketCap":8176593},{"date":"2024-06-28","current":-3.151843,"twenty":-29.039249,"median":-4.14073,"eighty":-3.17466,"marketCap":8395672},{"date":"2024-07-05","current":-3.076894,"twenty":-28.268006,"median":-4.123596,"eighty":-3.152177,"marketCap":8196027},{"date":"2024-07-12","current":-3.354803,"twenty":-27.364657,"median":-4.091549,"eighty":-3.151893,"marketCap":8936302},{"date":"2024-07-19","current":-3.424446,"twenty":-27.30175,"median":-4.069909,"eighty":-3.152177,"marketCap":9121812},{"date":"2024-07-26","current":-3.245364,"twenty":-26.987215,"median":-4.059882,"eighty":-3.155965,"marketCap":8644786},{"date":"2024-08-02","current":-3.170415,"twenty":-26.532395,"median":-4.049349,"eighty":-3.155965,"marketCap":8445141},{"date":"2024-08-09","current":-2.860669,"twenty":-25.67183,"median":-4.031441,"eighty":-3.149986,"marketCap":7620061},{"date":"2024-08-16","current":-3.389234,"twenty":-25.135933,"median":-4.020016,"eighty":-3.138179,"marketCap":7474546},{"date":"2024-08-23","current":-3.442191,"twenty":-23.755257,"median":-3.998229,"eighty":-3.149986,"marketCap":7591336},{"date":"2024-08-30","current":-3.591285,"twenty":-23.527315,"median":-3.997375,"eighty":-3.150782,"marketCap":7920144},{"date":"2024-09-06","current":-3.339536,"twenty":-22.646613,"median":-3.986524,"eighty":-3.151843,"marketCap":7364943},{"date":"2024-09-13","current":-3.258879,"twenty":-22.149646,"median":-3.973647,"eighty":-3.149853,"marketCap":7187064},{"date":"2024-09-20","current":-3.289839,"twenty":-20.759396,"median":-3.917197,"eighty":-3.150517,"marketCap":7255341},{"date":"2024-09-27","current":-3.614496,"twenty":-20.740524,"median":-3.899057,"eighty":-3.151843,"marketCap":7971334},{"date":"2024-10-04","current":-3.435673,"twenty":-20.363314,"median":-3.883719,"eighty":-3.152095,"marketCap":7576962},{"date":"2024-10-11","current":-3.250732,"twenty":-19.891275,"median":-3.853911,"eighty":-3.152506,"marketCap":7169096},{"date":"2024-10-18","current":-3.023425,"twenty":-19.564157,"median":-3.809472,"eighty":-3.150517,"marketCap":6667798},{"date":"2024-10-25","current":-3.055199,"twenty":-19.54214,"median":-3.784642,"eighty":-3.136671,"marketCap":6737872},{"date":"2024-11-01","current":-3.073115,"twenty":-19.532703,"median":-3.733861,"eighty":-3.110193,"marketCap":6777383},{"date":"2024-11-08","current":-2.857222,"twenty":-19.108615,"median":-3.676038,"eighty":-3.095553,"marketCap":6301258},{"date":"2024-11-15","current":-5.724859,"twenty":-17.33095,"median":-3.666688,"eighty":-3.076894,"marketCap":5390298},{"date":"2024-11-22","current":-5.556929,"twenty":-16.607515,"median":-3.683511,"eighty":-3.08413,"marketCap":5232182},{"date":"2024-11-29","current":-4.413865,"twenty":-13.892438,"median":-3.75724,"eighty":-3.085752,"marketCap":4155919},{"date":"2024-12-06","current":-5.553113,"twenty":-13.185991,"median":-3.785346,"eighty":-3.093674,"marketCap":5228589},{"date":"2024-12-13","current":-4.963452,"twenty":-12.929958,"median":-3.814538,"eighty":-3.095859,"marketCap":4673388},{"date":"2024-12-20","current":-4.368067,"twenty":-12.81987,"median":-3.860874,"eighty":-3.09997,"marketCap":4112797},{"date":"2024-12-27","current":-5.100849,"twenty":-12.71167,"median":-3.883719,"eighty":-3.106414,"marketCap":4802755},{"date":"2025-01-03","current":-8.791474,"twenty":-12.59592,"median":-3.898381,"eighty":-3.1101,"marketCap":8277700},{"date":"2025-01-10","current":-6.240095,"twenty":-12.505963,"median":-3.911149,"eighty":-3.111625,"marketCap":5875424},{"date":"2025-01-17","current":-7.20378,"twenty":-12.406569,"median":-3.952872,"eighty":-3.119608,"marketCap":6782791},{"date":"2025-01-24","current":-6.740066,"twenty":-12.210298,"median":-3.982649,"eighty":-3.128629,"marketCap":6346177},{"date":"2025-01-31","current":-7.776266,"twenty":-11.826564,"median":-3.988431,"eighty":-3.135261,"marketCap":7321821},{"date":"2025-02-07","current":-7.346902,"twenty":-11.637843,"median":-3.997893,"eighty":-3.136671,"marketCap":6917549},{"date":"2025-02-14","current":-7.079741,"twenty":-11.543482,"median":-3.998512,"eighty":-3.139115,"marketCap":6666001},{"date":"2025-02-21","current":-6.703809,"twenty":-10.989898,"median":-4.026503,"eighty":-3.147705,"marketCap":6312038},{"date":"2025-02-28","current":-6.249637,"twenty":-10.725687,"median":-4.032163,"eighty":-3.150384,"marketCap":5884408},{"date":"2025-03-07","current":-7.041576,"twenty":-10.691717,"median":-4.05506,"eighty":-3.151578,"marketCap":6630066},{"date":"2025-03-14","current":-6.679002,"twenty":-10.444492,"median":-4.064198,"eighty":-3.152045,"marketCap":6288681},{"date":"2025-03-21","current":-5.438616,"twenty":-10.380327,"median":-4.083617,"eighty":-3.152424,"marketCap":5120783},{"date":"2025-03-28","current":-4.772623,"twenty":-10.379698,"median":-4.101544,"eighty":-3.165257,"marketCap":4493711},{"date":"2025-04-04","current":-4.47684,"twenty":-9.249398,"median":-4.128883,"eighty":-3.169097,"marketCap":4215213},{"date":"2025-04-11","current":-5.018321,"twenty":-8.826544,"median":-4.140855,"eighty":-3.16926,"marketCap":4725050},{"date":"2025-04-17","current":-3.068623,"twenty":-8.256773,"median":-4.14066,"eighty":-3.162069,"marketCap":4904709},{"date":"2025-04-25","current":-3.237229,"twenty":-7.825882,"median":-4.123596,"eighty":-3.152342,"marketCap":5174199},{"date":"2025-05-02","current":-3.023661,"twenty":-7.747642,"median":-4.091549,"eighty":-3.151313,"marketCap":4832845},{"date":"2025-05-09","current":-3.001181,"twenty":-7.705659,"median":-4.069909,"eighty":-3.136429,"marketCap":4796913},{"date":"2025-05-16","current":-2.417617,"twenty":-7.678943,"median":-4.059882,"eighty":-3.135743,"marketCap":5120301},{"date":"2025-05-23","current":-2.400652,"twenty":-7.648411,"median":-4.049349,"eighty":-3.114489,"marketCap":5084369},{"date":"2025-05-30","current":-3.291353,"twenty":-7.625512,"median":-4.032112,"eighty":-3.104603,"marketCap":6970796},{"date":"2025-06-06","current":-2.731484,"twenty":-7.611772,"median":-4.023259,"eighty":-3.095706,"marketCap":5785042},{"date":"2025-06-13","current":-2.472756,"twenty":-7.600704,"median":-3.998512,"eighty":-3.079788,"marketCap":5237080},{"date":"2025-06-20","current":-2.485481,"twenty":-7.540784,"median":-3.99784,"eighty":-3.068818,"marketCap":5264029},{"date":"2025-06-27","current":-2.298857,"twenty":-7.34194,"median":-3.987477,"eighty":-3.057438,"marketCap":4868777},{"date":"2025-07-03","current":-5.454484,"twenty":-7.346902,"median":-3.987477,"eighty":-3.055293,"marketCap":11552118},{"date":"2025-07-11","current":-5.123652,"twenty":-7.322094,"median":-3.99784,"eighty":-3.057383,"marketCap":10851445},{"date":"2025-07-18","current":-5.624142,"twenty":-7.27057,"median":-3.997607,"eighty":-3.057659,"marketCap":11911438},{"date":"2025-07-25","current":-4.13964,"twenty":-7.251487,"median":-3.998512,"eighty":-3.064292,"marketCap":8767393},{"date":"2025-08-01","current":-5.878628,"twenty":-7.251487,"median":-3.998512,"eighty":-3.067241,"marketCap":12450417},{"date":"2025-08-08","current":-4.801304,"twenty":-7.251487,"median":-4.026503,"eighty":-3.068623,"marketCap":10168739},{"date":"2025-08-15","current":-4.546817,"twenty":-7.20378,"median":-4.032163,"eighty":-3.069598,"marketCap":9629759},{"date":"2025-08-22","current":-3.503537,"twenty":-7.079741,"median":-4.030769,"eighty":-3.073115,"marketCap":10276534},{"date":"2025-08-29","current":-3.534163,"twenty":-7.05875,"median":-4.009264,"eighty":-3.076894,"marketCap":10366364},{"date":"2025-09-05","current":-3.485162,"twenty":-7.045011,"median":-3.998229,"eighty":-3.082683,"marketCap":10222636},{"date":"2025-09-12","current":-2.634084,"twenty":-6.982037,"median":-3.997375,"eighty":-3.069403,"marketCap":7726265},{"date":"2025-09-19","current":-3.491287,"twenty":-6.965626,"median":-3.98472,"eighty":-3.072412,"marketCap":10240602},{"date":"2025-09-26","current":-3.67504,"twenty":-6.948451,"median":-3.964911,"eighty":-3.074449,"marketCap":10779582},{"date":"2025-10-03","current":-3.283035,"twenty":-6.899981,"median":-3.914173,"eighty":-3.076472,"marketCap":9629759},{"date":"2025-10-10","current":-3.295285,"twenty":-6.881279,"median":-3.898381,"eighty":-3.082683,"marketCap":9665691},{"date":"2025-10-17","current":-3.160534,"twenty":-6.873265,"median":-3.876866,"eighty":-3.085752,"marketCap":9270440},{"date":"2025-10-24","current":-3.178909,"twenty":-6.864105,"median":-3.859705,"eighty":-3.086858,"marketCap":9324338},{"date":"2025-10-31","current":-3.178909,"twenty":-6.837771,"median":-3.814538,"eighty":-3.087618,"marketCap":9324338},{"date":"2025-11-07","current":-3.197284,"twenty":-6.816398,"median":-3.785346,"eighty":-3.089629,"marketCap":9378236},{"date":"2025-11-14","current":-2.76853,"twenty":-6.754569,"median":-3.781989,"eighty":-3.087618,"marketCap":8120618},{"date":"2025-11-21","current":-3.402632,"twenty":-6.714114,"median":-3.746807,"eighty":-3.086858,"marketCap":7815196},{"date":"2025-11-28","current":-3.551075,"twenty":-6.705336,"median":-3.684446,"eighty":-3.087472,"marketCap":8156141},{"date":"2025-12-05","current":-3.386818,"twenty":-6.703809,"median":-3.672269,"eighty":-3.089163,"marketCap":7778875},{"date":"2025-12-12","current":-3.332066,"twenty":-6.700374,"median":-3.655837,"eighty":-3.09337,"marketCap":7653119},{"date":"2025-12-19","current":-4.250524,"twenty":-6.698084,"median":-3.672269,"eighty":-3.095782,"marketCap":9762642},{"date":"2025-12-26","current":-4.271108,"twenty":-6.690451,"median":-3.683511,"eighty":-3.097274,"marketCap":9809919},{"date":"2026-01-02","current":-4.065271,"twenty":-6.679002,"median":-3.740334,"eighty":-3.099622,"marketCap":9337152},{"date":"2026-01-09","current":-4.013812,"twenty":-6.679002,"median":-3.78062,"eighty":-3.102791,"marketCap":9218960},{"date":"2026-01-16","current":-3.797684,"twenty":-6.663736,"median":-3.784642,"eighty":-3.110069,"marketCap":8722554},{"date":"2026-01-23","current":-3.313968,"twenty":-6.60267,"median":-3.781989,"eighty":-3.110193,"marketCap":7611551},{"date":"2026-01-30","current":-2.727334,"twenty":-6.583587,"median":-3.746807,"eighty":-3.100979,"marketCap":6264165},{"date":"2026-02-06","current":-2.048073,"twenty":-6.570229,"median":-3.709154,"eighty":-3.090095,"marketCap":4704033},{"date":"2026-02-13","current":-2.089241,"twenty":-6.545421,"median":-3.67504,"eighty":-3.08413,"marketCap":4798587},{"date":"2026-02-20","current":-2.459747,"twenty":-6.530155,"median":-3.666688,"eighty":-3.072412,"marketCap":5649568},{"date":"2026-02-27","current":-2.572957,"twenty":-6.520232,"median":-3.632327,"eighty":-3.062965,"marketCap":5909590},{"date":"2026-03-06","current":-2.655291,"twenty":-6.512494,"median":-3.617356,"eighty":-3.054547,"marketCap":6098696},{"date":"2026-03-13","current":-2.295077,"twenty":-6.510941,"median":-3.606695,"eighty":-3.042673,"marketCap":5271354},{"date":"2026-03-20","current":-2.634708,"twenty":-6.417921,"median":-3.598152,"eighty":-3.023614,"marketCap":6051420},{"date":"2026-03-27","current":-2.562665,"twenty":-6.39314,"median":-3.589779,"eighty":-3.001181,"marketCap":5885951},{"date":"2026-04-02","current":-2.336244,"twenty":-6.309176,"median":-3.583137,"eighty":-3.000093,"marketCap":5365907},{"date":"2026-04-10","current":-2.314944,"twenty":-6.251164,"median":-3.558688,"eighty":-2.992433,"marketCap":5316985},{"date":"2026-04-17","current":-1.724758,"twenty":-6.247347,"median":-3.550311,"eighty":-2.980961,"marketCap":5147725},{"date":"2026-04-24","current":-1.806137,"twenty":-6.242385,"median":-3.534254,"eighty":-2.962996,"marketCap":5390610},{"date":"2026-05-01","current":-1.700847,"twenty":-6.231262,"median":-3.530385,"eighty":-2.947377,"marketCap":5076359},{"date":"2026-05-08","current":-1.684648,"twenty":-6.165508,"median":-3.517966,"eighty":-2.929618,"marketCap":5028013},{"date":"2026-05-15","current":-1.603655,"twenty":-6.116927,"median":-3.509425,"eighty":-2.911094,"marketCap":4786281},{"date":"2026-05-22","current":-1.68097,"twenty":-6.108368,"median":-3.503295,"eighty":-2.89209,"marketCap":4882974},{"date":"2026-05-29","current":-1.997192,"twenty":-6.10019,"median":-3.491287,"eighty":-2.867215,"marketCap":5801553},{"date":"2026-06-05","current":-1.909815,"twenty":-6.020695,"median":-3.485162,"eighty":-2.855672,"marketCap":5547735},{"date":"2026-06-12","current":-1.755865,"twenty":-5.908054,"median":-3.48459,"eighty":-2.809118,"marketCap":5100532},{"date":"2026-06-18","current":-2.097052,"twenty":-5.896604,"median":-3.479037,"eighty":-2.7762,"marketCap":6091631},{"date":"2026-06-26","current":-1.697613,"twenty":-5.893822,"median":-3.463798,"eighty":-2.732335,"marketCap":4931320},{"date":"2026-07-02","current":-1.66441,"twenty":-5.882693,"median":-3.458586,"eighty":-2.727334,"marketCap":4834869},{"date":"2026-07-10","current":-1.439726,"twenty":-5.878628,"median":-3.454537,"eighty":-2.696458,"marketCap":4182194},{"date":"2026-07-17","current":-1.37307,"twenty":-5.85653,"median":-3.450094,"eighty":-2.676654,"marketCap":3988568},{"date":"2026-07-24","current":-1.281531,"twenty":-5.761116,"median":-3.448412,"eighty":-2.663621,"marketCap":3722663},{"date":"2026-07-31","current":-1.098456,"twenty":-5.73211,"median":-3.446265,"eighty":-2.634583,"marketCap":3190854},{"date":"2026-08-07","current":-1.314818,"twenty":-5.724859,"median":-3.440255,"eighty":-2.61272,"marketCap":3819356},{"date":"2026-08-14","current":-1.364748,"twenty":-5.724859,"median":-3.432415,"eighty":-2.603832,"marketCap":3964394},{"date":"2026-08-21","current":-1.489269,"twenty":-5.712645,"median":-3.424179,"eighty":-2.577625,"marketCap":3835068},{"date":"2026-08-25","current":-1.765669,"twenty":-5.708224,"median":-3.423912,"eighty":-2.572957,"marketCap":4546835}],"updateTime":1787803564818},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BGLC\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659217621","title":"BioNexus Q2 FY26 Net Loss Narrows 53.51% to $286,451; Revenue Drops 96.63% to $76,156 vs Year-Ago Quarter","url":"https://stock-news.laohu8.com/highlight/detail?id=2659217621","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659217621?lang=en_us&edition=fundamental","pubTime":"2026-08-15 05:07","pubTimestamp":1786741671,"startTime":"0","endTime":"0","summary":"BioNexus Q2 FY26 net loss narrows 53.51% to $286,451; revenue drops 96.63% to $76,156 vs year-ago quarterBioNexus Gene Lab posted a net loss attributable to common shareholders of USD 286,451, narrowi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL1B9VRs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4104","BGLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657462690","title":"BioNexus Gene Lab Files Initial Beneficial Ownership Statement for Fidelion Diagnostics Pte. Ltd","url":"https://stock-news.laohu8.com/highlight/detail?id=2657462690","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657462690?lang=en_us&edition=fundamental","pubTime":"2026-08-08 04:28","pubTimestamp":1786134537,"startTime":"0","endTime":"0","summary":"BioNexus Gene Lab files initial beneficial ownership statement for Fidelion Diagnostics Pte. LtdBioNexus Gene Lab filed a Form 3 showing Fidelion Diagnostics beneficially owns 392,329 common shares as","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nNDL9fp9VL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4104","BGLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656102391","title":"BioNexus Gene Lab Names CFO Chong Set Fui in Initial Beneficial Ownership Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2656102391","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656102391?lang=en_us&edition=fundamental","pubTime":"2026-08-01 05:01","pubTimestamp":1785531672,"startTime":"0","endTime":"0","summary":"BioNexus Gene Lab names CFO Chong Set Fui in initial beneficial ownership filingBioNexus Gene Lab filed an initial Form 3 for CFO Chong Set Fui, dated June 17, 2025.Disclaimer:This news brief was crea","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nNDL1n5q7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BGLC","BK4104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654002032","title":"BioNexus Advances VitaGuard Southeast Asia Rollout After China Hospital Visits","url":"https://stock-news.laohu8.com/highlight/detail?id=2654002032","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654002032?lang=en_us&edition=fundamental","pubTime":"2026-07-28 21:00","pubTimestamp":1785243627,"startTime":"0","endTime":"0","summary":"BioNexus advances VitaGuard Southeast Asia rollout after China hospital visitsBioNexus attended a working visit to Tongshu Gene facilities in Shanghai and Changzhou to advance the VitaGuard MRD platfo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nNDLP5XJ5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2T93.GBP","BK4585","IE00BN0W2W23.USD","LU0314104364.USD","SG9999014021.USD","IE00B64PRP62.GBP","LU2210149790.SGD","BK4112","SG9999014005.SGD","IE00BN0W2V16.EUR","IE00B3QW5Z07.USD","BK4104","NDAQ","IE00BGHQF748.EUR","LU2210150020.SGD","IE00BKPKM429.USD","BCDF","SG9999014039.USD","SG9999014013.SGD","BK4588","BGLC","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642783544","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 01:15 PM","url":"https://stock-news.laohu8.com/highlight/detail?id=2642783544","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642783544?lang=en_us&edition=fundamental","pubTime":"2026-06-11 01:15","pubTimestamp":1781111756,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 01:15 PM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nAQN2M2ZRB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BGLC","BK4104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641114353","title":"BioNexus CEO speaks at China-Malaysia Economic Cooperation Outlook Forum in Kuala Lumpur","url":"https://stock-news.laohu8.com/highlight/detail?id=2641114353","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641114353?lang=en_us&edition=fundamental","pubTime":"2026-06-05 21:02","pubTimestamp":1780664551,"startTime":"0","endTime":"0","summary":"BioNexus attended the 2026 China-Malaysia Economic Cooperation Outlook Forum on May 21, 2026 in Kuala Lumpur.CEO Sam Tan urged Malaysia-China biotech collaboration to shift from trade to co-development, citing a precision-health corridor anchored by VitaGuard MRD commercialization.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioNexus Gene Lab Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 05, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260605:nNDLMfBbQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BGLC","BK4104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639206906","title":"BioNexus Gene Lab CEO urges Malaysia-China biotech co-development at economic forum in Kuala Lumpur","url":"https://stock-news.laohu8.com/highlight/detail?id=2639206906","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639206906?lang=en_us&edition=fundamental","pubTime":"2026-05-29 21:00","pubTimestamp":1780059629,"startTime":"0","endTime":"0","summary":"BioNexus attended the 2026 China-Malaysia Economic Cooperation Outlook Forum on May 21 in Kuala Lumpur under a biotechnology and healthcare collaboration theme.CEO Sam Tan urged Malaysia-China co-development beyond trade, positioning Malaysia as an ASEAN hub for clinical validation and commercialization of China-origin precision diagnostics.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nNDL7C2Py0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","IE00BN0W2W23.USD","BK4112","SG9999014039.USD","IE00BN0W2V16.EUR","BGLC","IE00BN0W2T93.GBP","IE00B64PRP62.GBP","SG9999014005.SGD","LU2095319765.USD","SG9999014013.SGD","LU2210150020.SGD","SG9999014021.USD","IE00BKPKM429.USD","LU0314104364.USD","IE00BGHQF748.EUR","NDAQ","BK4585","BK4588","LU2210149790.SGD","BK4104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639620418","title":"BioNexus Gene Lab Corp. Calls for Malaysia–China Biotechnology Cooperation to Move Beyond Trade into Co-Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2639620418","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639620418?lang=en_us&edition=fundamental","pubTime":"2026-05-29 21:00","pubTimestamp":1780059600,"startTime":"0","endTime":"0","summary":"Sam Tan, Chief Executive Officer of BioNexus Gene Lab Corp. , speaking at the 2026 China–Malaysia Economic Cooperation Outlook Forum in Kuala Lumpur, where he discussed moving biotechnology cooperation beyond trade into co-development and building a Malaysia–China precision healthcare corridor.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/29/3303612/0/en/BioNexus-Gene-Lab-Corp-Calls-for-Malaysia-China-Biotechnology-Cooperation-to-Move-Beyond-Trade-into-Co-Development.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IXJ","BK4550","BK4585","BK4104","BK4588","BGLC","VHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635005800","title":"BioNexus Q1 FY26 net loss narrows to $543,575; revenue drops 98.93% to $22,842","url":"https://stock-news.laohu8.com/highlight/detail?id=2635005800","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635005800?lang=en_us&edition=fundamental","pubTime":"2026-05-16 05:20","pubTimestamp":1778880040,"startTime":"0","endTime":"0","summary":"BioNexus Gene Lab posted Q1 net loss attributable to common shareholders of USD 543,575, narrowing from a loss of USD 623,327 a year earlier; revenue plunged 98.93% to USD 22,842.Operating loss improved 12% to USD 540,490, while operating expenses fell 43% to USD 597,386.Chemrex revenue dropped 98.99% to USD 21,531, with gross margin swinging to -6.66% from 16.02% a year earlier due to direct manufacturing costs despite low production volumes.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioNexus Gene Lab Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 15, 2026, and is solely ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDLBWYHM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BGLC","BK4104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627842213","title":"BioNexus Gene Lab FY25 net loss widens 86.7% to $2.98 million; revenue falls 21.9% to $7.42 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2627842213","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627842213?lang=en_us&edition=fundamental","pubTime":"2026-04-15 05:21","pubTimestamp":1776201682,"startTime":"0","endTime":"0","summary":"BioNexus Gene Lab posted a net loss attributable to common shareholders of USD 3 million for fiscal 2025, widening from the prior year.Working capital slipped to USD 4.9 million at Dec. 31, 2025, while net cash used in operating activities narrowed to USD 1.8 million.Management cited lower sales volume at Chemrex, higher holding-company general and administrative expenses, and financing and strategic transactions tied to Fidelion and ARC; plans include liquidity management, Chemrex performance improvement, internal control remediation, and pursuing external financing.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioNexus Gene Lab Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gath","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260414:nNDLncsTY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BGLC","BK4104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624076553","title":"BioNexus Gene Lab expects delayed 2025 10-K filing after governance review","url":"https://stock-news.laohu8.com/highlight/detail?id=2624076553","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624076553?lang=en_us&edition=fundamental","pubTime":"2026-04-01 05:26","pubTimestamp":1774992396,"startTime":"0","endTime":"0","summary":"BioNexus Gene Lab disclosed it will miss filing its annual report on Form 10-K for fiscal year ended Dec. 31, 2025.Delay follows an enhanced review of transactions during the 12 months ended Dec. 31, 2025 tied to potential governance lapses.Company expects to file within 15 calendar days of original due date under SEC Rule 12b-25.Management does not anticipate a significant change in results of operations versus prior-year period.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioNexus Gene Lab Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 31, 2026, and is solely responsible","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDL1dqHtX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4104","BGLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620472776","title":"BioNexus Gene Lab names Muthu Meyyappan chief commercial officer of Fidelion Diagnostics","url":"https://stock-news.laohu8.com/highlight/detail?id=2620472776","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620472776?lang=en_us&edition=fundamental","pubTime":"2026-03-18 02:30","pubTimestamp":1773772253,"startTime":"0","endTime":"0","summary":"BioNexus Gene Lab said Muthu Meyyappan was appointed chief commercial officer of Fidelion to lead global commercialization and partnerships for the VitaGuard MRD platform. Meyyappan has more than 15 years of experience in precision oncology diagnostics, genomics, and liquid biopsy commercialization. He previously held senior commercial leadership roles at Menarini Silicon Biosystems, Congenica, Variantyx, and QIAGEN. Most recently, he served as global chief commercial officer at Menarini Silicon Biosystems and earlier was chief commercial officer at Variantyx.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioNexus Gene Lab Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, A","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nNDL9jCY47:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4104","BGLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618947993","title":"Press Release: BioNexus Gene Lab Corp. Announces Appointment of Dr. Muthu Meyyappan as Chief Commercial Officer of Fidelion Diagnostics to Lead Global Commercialization of the VitaGuard(TM) MRD Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2618947993","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618947993?lang=en_us&edition=fundamental","pubTime":"2026-03-11 20:45","pubTimestamp":1773233100,"startTime":"0","endTime":"0","summary":"KUALA LUMPUR, Malaysia, March 11, 2026  -- BioNexus Gene Lab Corp.  today announced that, in connection with its Fidelion Diagnostics Pte. Ltd  transaction, Dr. Muthu Meyyappan has been appointed Chief Commercial Officer of Fidelion. Fidelion is a precision diagnostics company focused on advancing next-generation oncology testing technologies, including minimal residual disease  liquid biopsy assays. Fidelion serves as the international intellectual property and commercialization vehicle for the VitaGuard MRD technology developed by Tongshu Gene, supporting commercialization initiatives outside Greater China. BGLC is a strategic investor in Fidelion and holds exclusive commercialization rights for VitaGuard across Southeast Asia through its licensing arrangement with Fidelion.Dr. Meyyappan will lead Fidelion's global commercial strategy and partnerships, including the development of clinical, laboratory, and pharmaceutical collaborations to support the adoption of advanced oncology dia","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03160","BK4555","BK4604","BGLC","BK4232","BK4104","BK4099","TM","BK4022","BK4588","R","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613877507","title":"Bionexus Gene Lab appoints Matthew Barsing as Chairman","url":"https://stock-news.laohu8.com/highlight/detail?id=2613877507","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613877507?lang=en_us&edition=fundamental","pubTime":"2026-02-23 21:49","pubTimestamp":1771854579,"startTime":"0","endTime":"0","summary":"BioNexus Gene Lab (BGLC) announced the completion of a governance restructuring of its wholly owned subsidiary, Chemrex Corporation. As part of thi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bionexus-gene-lab-appoints-matthew-barsing-as-chairman-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bionexus-gene-lab-appoints-matthew-barsing-as-chairman-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4104","BGLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613078222","title":"BioNexus Subsidiary Chemrex Names Matthew Barsing Chairman","url":"https://stock-news.laohu8.com/highlight/detail?id=2613078222","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613078222?lang=en_us&edition=fundamental","pubTime":"2026-02-23 21:30","pubTimestamp":1771853445,"startTime":"0","endTime":"0","summary":"BioNexus Gene Lab Corp. completed a governance restructuring of its wholly owned subsidiary, Chemrex Corporation Sdn. Bhd., streamlining Chemrex’s board to two directors: Matthew L. Barsing as chairman and BioNexus CFO Angeline Chong as director. BioNexus said it is evaluating potential expansion initiatives at Chemrex, including biotechnology-focused development opportunities, under a staged capital allocation framework approved in July 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioNexus Gene Lab Corp. published the original content used to generate this news brief via GlobeNewswire  on February 23, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nNDL4q7Lwm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","NDAQ","LU2210150020.SGD","LU0314104364.USD","LU2095319765.USD","BK4104","LU2210149790.SGD","SG9999014013.SGD","IE00BKPKM429.USD","SG9999014005.SGD","BK4588","SG9999014039.USD","SG9999014021.USD","IE00BGHQF748.EUR","BGLC","IE00B3QW5Z07.USD","BK4112","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613246782","title":"BioNexus Gene Lab Corp. Completes Chemrex Governance Restructuring; Appoints Matthew Barsing as Chairman","url":"https://stock-news.laohu8.com/highlight/detail?id=2613246782","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613246782?lang=en_us&edition=fundamental","pubTime":"2026-02-23 21:30","pubTimestamp":1771853401,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nTUA8YBGNT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BGLC","BK4104"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":16,"code":"91000000","status":"200"}]}}